Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Fuji
Covington
Boehringer Ingelheim
Colorcon
Cipla
Johnson and Johnson
AstraZeneca
Mallinckrodt

Generated: May 25, 2018

DrugPatentWatch Database Preview

DYCLONE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Dyclone, and when can generic versions of Dyclone launch?

Dyclone is a drug marketed by Astrazeneca and is included in one NDA.

The generic ingredient in DYCLONE is dyclonine hydrochloride. There are four drug master file entries for this compound. Additional details are available on the dyclonine hydrochloride profile page.
Summary for DYCLONE
Drug patent expirations by year for DYCLONE
Synonyms for DYCLONE
1-(4-Butoxyphenyl)-3-(1-piperidinyl)-1-propanone hydrochloride
1-(4-butoxyphenyl)-3-(1-piperidyl)propan-1-one hydrochloride
1-(4-butoxyphenyl)-3-piperidin-1-ylpropan-1-one hydrochloride
1-(4-butoxyphenyl)-3-piperidin-1-ylpropan-1-one;hydrochloride
1-(4-butoxyphenyl)-3-piperidylpropan-1-one, chloride
1-Propanone, 1-(4-butoxyphenyl)-3-(1-piperidinyl)-, hydrochloride
1-Propanone, 1-(4-butoxyphenyl)-3-(1-piperidinyl)-, hydrochloride (9CI)
1-Propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-, hydrochloride (1:1)
4-n-Butoxy-.beta.-(1-piperidyl)propiophenone hydrochloride
4-n-Butoxy-beta-(1-piperidyl)propiophenone hydrochloride
4'-Butoxy-3-piperidinopropiophenone hydrochloride
536-43-6
586-60-7 (Parent)
AB0018094
AB1009570
AC-8346
AC1L29GY
AC1Q3DUL
ACN-025344
AKOS015951364
AN-8074
API0008891
BC204343
C 5422
C18H28ClNO2
CAS-536-43-6
CCG-40231
CHEBI:4725
CHEMBL1200478
CS-2421
CTK8F9398
D00735
D4303
DSSTox_CID_25323
DSSTox_GSID_45323
DSSTox_RID_80802
DTXSID6045323
Dyclocaine hydrochloride
Dyclone (TN)
Dyclonine (hydrochloride)
Dyclonine HCL
Dyclonine hydrochlori
Dyclonine hydrochloride
Dyclonine hydrochloride (USP)
Dyclonine hydrochloride [USP]
Dyclonine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Dyclonine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Dyclonine, Hydrochloride
Dycloninehydrochloride
Dyclothane
EINECS 208-633-6
FT-0625635
HMS1568F10
HMS1920K06
HY-B0364A
KNZADIMHVBBPOA-UHFFFAOYSA-N
KS-00000G4E
LS-125086
MFCD00035386
MLS000069532
MLS001077359
MLS002222240
MolPort-003-666-173
NCGC00016498-01
NCGC00016498-08
NCGC00094662-01
NCGC00094662-02
NCGC00094662-03
NCGC00094662-04
NSC 23018
NSC-23018
NSC-25588
NSC-756745
NSC23018
NSC25588
NSC756745
Opera_ID_1265
P-267
Pharmakon1600-01500268
Piperidine, 1-(2-(4-butoxybenzoyl)ethyl), hydrochloride
Prestwick_674
Propiophenone, 4'-butoxy-3-piperidino-, hydrochloride
S 154
s2041
SBB058147
SC-46932
SCHEMBL317219
SMR000038382
SPECTRUM1500268
ST086519
Sulfourea; Thiocarbamide
Tanaclone
Tox21_110459
Tox21_110459_1
UNII-ZEC193879Q
W-105718
WLN: T6NTJ A2VR DO4 &GH
ZEC193879Q

US Patents and Regulatory Information for DYCLONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca DYCLONE dyclonine hydrochloride SOLUTION;TOPICAL 009925-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca DYCLONE dyclonine hydrochloride SOLUTION;TOPICAL 009925-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Julphar
Chubb
Healthtrust
Boehringer Ingelheim
Fuji
Accenture
Cantor Fitzgerald
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.